Finance

Beta
Lists
131030:KOSDAQ
Optus Pharmaceutical Co Ltd
â‚©6,290.00
+8.64%
(+500.00) 1D
Jun 12, 3:30:17 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 131030...
Open
â‚©6,100
High
â‚©6,520
Low
â‚©5,890
Mkt. cap
111.00B
Avg. vol.
125.93K
Volume
219.13K
P/E ratio
7.88
52-wk high
â‚©20,750
52-wk low
â‚©5,440
EPS
â‚©798
Shares outstanding
17.65M
No. of employees
264
Open
â‚©6,100
High
â‚©6,520
Low
â‚©5,890
Mkt. cap
111.00B
Avg. vol.
125.93K
Volume
219.13K
P/E ratio
7.88
52-wk high
â‚©20,750
52-wk low
â‚©5,440
EPS
â‚©798
Shares outstanding
17.65M
No. of employees
264
News stories
From sources across the web
About Optus Pharmaceutical Co Ltd
CEO-
Employees264
Founded2002
Headquarters-
SectorMedical device
Websiteoptuspharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
21.79B
24.07B
22.56B
23.19B
Cost of goods sold
9.87B
10.74B
10.73B
9.53B
Cost of revenue
9.87B
10.74B
10.73B
9.53B
Research and development expenses
342.97M
338.80M
609.50M
445.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.18B
9.35B
9.08B
9.75B
Operating expense
8.84B
10.11B
10.18B
10.76B
Total operating expenses
18.72B
20.85B
20.91B
20.29B
Operating income
3.07B
3.22B
1.66B
2.90B
Other non operating income
-46.96M
982.02K
395.21M
-5.81M
EBT including unusual items
3.38B
3.60B
2.70B
3.12B
EBT excluding unusual items
3.38B
3.64B
2.25B
3.10B
Income tax expense
531.13M
407.59M
-1.43B
606.19M
Effective tax rate
15.71%
11.31%
-53.07%
19.44%
Other operating expenses
52.33M
62.54M
38.69M
69.34M
Net income
2.85B
3.20B
4.14B
2.51B
Net profit margin
13.08%
13.28%
18.33%
10.83%
Earnings per share
-
-
-
-
Interest and investment income
357.26M
295.68M
236.91M
204.05M
Interest expense
-18.04M
-17.32M
-14.97M
-17.69M
Net interest expenses
339.22M
278.35M
221.94M
186.36M
Depreciation and amortization charges
315.86M
360.87M
444.87M
495.38M
EBITDA
4.21B
4.40B
2.92B
4.22B
Gain or loss from assets sale
-612.88K
38.28M
-89.69K
-2.98M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer